{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:22:49Z","timestamp":1772065369619,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/bjd.15767","type":"journal-article","created":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T03:31:07Z","timestamp":1515814267000},"page":"1475-1476","source":"Crossref","is-referenced-by-count":4,"title":["Considering the role of health economics in pyoderma gangrenosum and other dermatology research"],"prefix":"10.1093","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7646-5435","authenticated-orcid":false,"given":"N.","family":"Bray","sequence":"first","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation; Bangor University; Ardudwy, Normal Site, Bangor Gwynedd LL57 2PZ U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"10.1111\/bjd.15767-BIB0001|bjd15767-cit-0001","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/bjd.15561","article-title":"Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial","volume":"177","author":"Mason","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15767-BIB0002|bjd15767-cit-0002","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"10.1111\/bjd.15767-BIB0003|bjd15767-cit-0003","volume-title":"Social Value Judgements: Principles for the Development of NICE Guidance","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1111\/bjd.15767-BIB0004|bjd15767-cit-0004","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Care Excellence","year":"2013"},{"key":"10.1111\/bjd.15767-BIB0005|bjd15767-cit-0005","volume-title":"What is a QALY?","author":"Phillips","year":"2009"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15767","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15767\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:28:25Z","timestamp":1676384905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/177\/6\/1475\/6697348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15767","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}